NIPA Antibody 4497S from Cell Signaling Technology

Product Specs
ItemNIPA Antibody
CompanyCell Signaling Technology
Price Pricing Info Supplier Page View Company Product Page
Catalog Number4497S
Quantity100 µl
ApplicationsW
ReactivityH, Mk
TargetNIPA
HostRabbit
NCBI Gene AliasesHSPC216, NIPA
NCBI Full Gene Namezinc finger C3HC-type containing 1
ClonalityPolyclonal
Research AreaCell Cycle / Checkpoint Control
Molecular Weight60-65 kDa

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinomaExperimental Cell ResearchMay 1, 2022Julia Ingruber, József Dudás, Dragana Savic, Gabrielle Schweigl, Teresa Bernadette Steinbichler, Maria do Carmo Greier, Matthias Santer, Sandro Carollo, Zlatko Trajanoski, Herbert RiechelmannUK",1:800 anti-Slug,Rabbit IgG,9585,"Cell Signalling, Danvers, MA, USA",1:30 anti-E-cadherin,Mouse IgG2a,790–4497,"Roche Ventana, Mannheim, Germany",prediluted anti-HSP70,Mouse IgG2b,"818,101","Biolegend, California,

(2) Loss of Aurora Kinase Signaling Allows Lung Cancer Cells to Adopt Endoreplication and Form Polyploid Giant Cancer Cells That Resist Antimitotic DrugsCancer researchJanuary 15, 2021Tagal V, Roth MG.F6627), Aphidicollin (Calbiochem, 178273), Bafilomycin A (Sigma-Aldrich, B1793), Erlotinib (LC Labs, E-4497) were purchased in powder form and stored at 10 mM or 20 mM stock concentrations in dimethyl sulfoxide (DMSO

(3) Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung CancerClinical cancer research : an official journal of the American Association for Cancer ResearchJanuary 1, 2020Recondo G, Mezquita L, Facchinetti F, Planchard D, Gazzah A, Bigot L, Rizvi AZ, Frias RL, Thiery JP, Scoazec JY, et al.Cell Signaling Technology. For IHC assays the antibodies used were ALK (#6679072001), E-Cadh (#790-4497) and CD31 (#760-4378) purchased from Ventana; N-Cadh (#M3613), Ki-67 (#M7240), beta catenin (#M3539),

(4) mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3Proceedings of the National Academy of Sciences of the United States of AmericaOctober 23, 2018Shi G, Ozog S, Torbett BE, Compton AA.

(5) Tri-methylation of ATF7IP by G9a/GLP recruits the chromodomain protein MPP8Epigenetics & chromatinOctober 4, 2018Tsusaka T, Kikuchi M, Shimazu T, Suzuki T, Sohtome Y, Akakabe M, Sodeoka M, Dohmae N, Umehara T, Shinkai Y.

(6) d-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patientsLipids in Health and DiseaseJuly 21, 2018Asaf A. Qureshi, Dilshad A. Khan, Shahida Mushtaq, Shui Qing Ye, Min Xiong, Nilofer Qureshi

(7) Update on the Biology and Therapy of Gastrointestinal Stromal TumorsCancer ControlJanuary 26, 2005Gina D'amato, Dejka M. Steinert, John C. Mcauliffe, Jonathan C. TrentMcConkey DJ, Loughlin SM, et al. Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J. 1996;15:4497-4505. 33. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211-225. 34. Majumder

Be the First to Write a Review!

NIPA Antibody

NIPA Antibody from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (7)

Reviews

NIPA Antibody from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map